AFFF Lawsuit 2026: The PFAS Blood Test — What Your Level Proves and How It Strengthens Your Claim

One laboratory result has become the most persuasive single document in firefighting foam litigation: a PFAS blood test. For firefighters, service members and airport workers suing over AFFF exposure, a serum PFAS level puts a number on the "forever chemicals" still in your body years after the last training fire — and plaintiffs' experts are using those numbers in 2026.

AFFF (aqueous film-forming foam) is a firefighting foam used since the 1970s to smother fuel fires at military bases, airports and refineries. Legacy AFFF was made with PFOS and PFOA, two of the most persistent PFAS chemicals ever produced. A PFAS blood test — properly a serum PFAS panel — measures the concentration of specific PFAS compounds in blood, reported in nanograms per milliliter (ng/mL).

Key facts

  • More than 15,000 AFFF personal injury claims are pending in MDL-2873 in the U.S. District Court for the District of South Carolina.
  • The CDC has found PFAS in the blood of roughly 97% of Americans tested — so a positive result alone proves nothing; the level and the compound pattern are what matter.
  • The National Academies' 2022 clinical guidance uses the sum of seven PFAS in serum: below 2 ng/mL, adverse effects are not expected; 2–20 ng/mL signals potential risk; 20 ng/mL or above marks the highest-risk tier meriting clinical follow-up.
  • PFOS, the signature chemical in legacy AFFF, has a half-life in human blood of roughly 3 to 5 years — meaning foam exposure from the 1990s can still register today.
  • 3M's $12.5 billion and DuPont's $1.185 billion settlements compensate public water systems, not individual firefighters — personal injury claims proceed separately in the MDL.

Why a blood level matters more than a positive result

Because PFAS are everywhere — in food packaging, stain-resistant fabrics and drinking water — nearly everyone's blood contains some. Defense lawyers know this, and their standard argument is that a plaintiff's PFAS came from ordinary life, not from foam. A serum panel answers that argument in two ways. First, magnitude: career firefighters and foam-handling personnel routinely test far above general-population levels, particularly for PFOS. Second, fingerprint: the panel reports individual compounds, and a profile dominated by PFOS and PFHxS — the compounds characteristic of firefighting foam — looks very different from the profile of someone whose exposure came mainly from consumer products.

The National Academies of Sciences, Engineering, and Medicine gave these numbers official weight in 2022, when its guidance told clinicians to offer PFAS blood testing to people with likely elevated exposure and to use the three-tier serum framework — under 2, 2 to 20, and over 20 ng/mL — to guide screening for kidney function, thyroid disease, cholesterol and certain cancers. When a plaintiff's combined level lands in the top tier, it becomes difficult for a defense expert to describe the exposure as trivial.

How to get tested — and what it costs

A serum PFAS panel can be ordered through your physician or directly through national laboratories that offer PFAS panels measuring PFOA, PFOS, PFHxS, PFNA and other compounds. As a cost of services, expect the test itself to run a few hundred dollars when paid out of pocket; some veterans' organizations, fire departments and state programs cover testing for personnel with documented foam exposure, and plaintiffs' firms frequently arrange testing as part of a case workup. Ask for the full compound-by-compound report, not a single total — the fingerprint is the evidence.

Timing deserves one caution. PFAS levels decline slowly after exposure ends, so a test taken today cannot perfectly reconstruct a 1995 level. Experts handle this with back-extrapolation using known half-lives and your exposure history — another reason the test works best alongside service and employment records rather than instead of them. Our overview of which cancers qualify for an AFFF claim shows where the blood evidence fits into the larger eligibility picture.

What the test cannot do on its own

A blood result proves exposure; it does not by itself prove which product you used, where, or that the exposure caused your disease. A complete AFFF claim still needs employment or service records placing you at locations where AFFF was used, training and incident records showing foam contact, and medical records documenting a qualifying diagnosis such as kidney or testicular cancer. Think of the serum level as the keystone: it converts "I believe I was exposed" into a measured fact that the rest of the file then explains.

If you have never been tested, that is not a barrier to filing — thousands of MDL plaintiffs established exposure through records alone, and testing can happen during the case. But if you are a retired firefighter or veteran with a qualifying diagnosis and no test yet, getting one is among the highest-value steps you can take this year. The procedural side of filing is covered in our guide to choosing an AFFF lawyer and filing your claim.

Where the litigation stands in 2026

The personal injury cases in MDL-2873 continue through bellwether preparation, with the court and the parties working through expert challenges on exactly the questions a blood test helps answer: how much PFAS exposure is enough, and which diseases it can cause. Meanwhile the water-system settlements are paying out to utilities — money that does nothing for an individual firefighter's medical bills, which is why the personal injury track remains essential. Compensation in the injury cases varies widely by case, and most settlements are confidential; no ethical lawyer will promise you a number before your exposure file is built.

For short, plain-English video breakdowns of PFAS and other lawsuit topics, the Problem Solved YouTube channel explains new developments in clear episodes.

Who Benefits From This — and Who Does Not

A PFAS blood test is most useful to readers who already have a plausible foam-exposure history and a qualifying diagnosis, because the test's value lies in the level and the compound pattern, not in a simple positive result.

Who benefits:

  • Career firefighters, service members and airport workers with foam exposure: How: pair the serum panel with service and employment records and medical records of a qualifying diagnosis such as kidney or testicular cancer.
  • Retired firefighters or veterans with a qualifying diagnosis but no test yet: How: getting tested is among the highest-value steps available, and testing can also be arranged during a case.
  • Readers whose combined level reaches the top tier: How: ask for the full compound-by-compound report, not a single total — a profile dominated by PFOS and PFHxS is the fingerprint of foam exposure.

Who benefits less, or not at all:

  • Anyone with only a positive result: The CDC found PFAS in the blood of roughly 97% of Americans tested, so a positive result alone proves nothing.
  • Anyone expecting the test alone to carry a case: A complete claim still needs exposure records and a documented diagnosis.
  • Anyone seeking individual money from the water-system settlements: 3M's $12.5 billion and DuPont's $1.185 billion settlements compensate public water systems, not individual firefighters — personal injury claims proceed separately in MDL-2873.

Read more: the overview of which cancers qualify for an AFFF claim

Frequently asked questions

What PFAS blood level is considered high?

Under the National Academies' 2022 guidance, a combined serum level of seven PFAS compounds at or above 20 ng/mL falls in the highest tier, where clinicians are advised to pursue follow-up screening. Levels between 2 and 20 ng/mL indicate potential increased risk, and below 2 ng/mL adverse effects are not expected.

Do I need a blood test to file an AFFF lawsuit?

No. Many plaintiffs prove exposure through service records, training logs and employment history alone, and testing can be arranged after filing. A test strengthens a case — especially a high PFOS result — but its absence does not disqualify you.

Can a blood test prove my PFAS came from firefighting foam?

Not by itself, but it can come close: a profile dominated by PFOS and PFHxS at levels far above the general population is characteristic of foam exposure, and experts use the compound pattern, the level, and your work history together to attribute the source.

How much does a PFAS blood test cost?

Paid out of pocket, a serum PFAS panel typically costs a few hundred dollars as a laboratory service. Some departments, veterans' programs and state initiatives cover testing for exposed personnel, and law firms often arrange it during a case workup.

Who benefits most from a PFAS blood test — and who does not?

Foam-exposed personnel with a qualifying diagnosis benefit most, especially with a high PFOS-led profile in the top tier of the National Academies' framework (20 ng/mL or above for the sum of seven PFAS). It does not help someone with only background-level PFAS, or someone expecting the test alone to prove a case — exposure records and a documented diagnosis are still required.

How do I get a PFAS blood test and use it in a claim?

Order a serum PFAS panel through your physician or a national laboratory, and ask for the full compound-by-compound report, not a single total. Paid out of pocket, the test typically costs a few hundred dollars; some departments, veterans' programs and state initiatives cover testing, and firms often arrange it during a case workup. Combine the result with your records, since levels decline slowly after exposure ends — PFOS has a half-life of roughly 3 to 5 years — and experts use back-extrapolation from your exposure history.

This article is general information about an ongoing litigation, not legal or medical advice. If you handled AFFF and have been diagnosed with a serious illness, consult a qualified attorney about your specific situation.

Watch on YouTube

Problem Solved on YouTube